INTRODUCTION AND OBJECTIVES: Arterial clamping is often needed for laparoscopic partial nephrectomy (LPN) to control the hemorragic risk. It induces a transitory renal ischemia, the long-term consequences of which are controversial. In order to limit ischemia and operative bleeding we developed a LPN technique without arterial clamping, in a hybrid operating room, after hyperselective tumoral embolization (HSE). We evaluated the feasibility after 36 successive cases.
METHODS: Between May 2015 and October 2016, 16 female and 20 male presenting a localized renal tumor were included. Median age and BMI were 59 y (32-82) and 25,9 kg/m2 (20,1-37,4) . 11 patients had a biopsy prior to surgery. Three indications of partial surgery were imperative, one was preventive and all other were elective. Respectively 24 and 4 tumors were of moderate and high complexity according to the RENAL Score. One singel interventional radiologist performed the HSE of tumoral vessels and controled the vascular exclusion of the tumor. Afterwards one single urologist performed a clampless LPN without dissection of the renal pedicle. If necessary, a suture of the parenchyma was made to control venous bleeding.
RESULTS: Median endovascular and surgical procedures durations were 45 min (21-120) and 77,5 min (32-150). Median blood loss was 50 mL (10-650). No peroperative transfusion was needed. One surgery was converted to a mini-laparotomy because of toxic fat, in order to control carcinological margins. Two Clavien II complications were a postoperative transfusion on a fragile patient and an unexplained sepsis. Median length of stay was 3,5 days (2-7). The procedure had no impact on renal function after one month of follow-up (p¼0,09). Median tumoral size was 3 cm (1,5-8). Twenty-eight tumors (77.8%) were malignant. Surgical margins were postive for one patient (2,8%).
CONCLUSIONS: Clampless LPN in a hybrid operating room without pedicular dissection after previous tumoral embolization is a technically safe and carcinologically efficient mini-invasive alternative for the management of localized renal tumors. RESULTS: Median tumor diameter was 7.2 cm (interquartile range [IQR]: 5e8.5 cm), and the median nephrometry score was 9 (IQR: 7-10). Six patients (15%) had a history of tuberous sclerosis, and 11 (28%) had previously undergone SAE. Median operative time and median warm ischemia time were 207 minutes (IQR: 180-231) and 22.5 minutes (IQR: 16-28), respectively. Non-clamping technique was applied in 8 (20%) patients. Median blood loss was 200 ml (IQR: 100-245), and 4 patients (10%) received blood transfusion postoperatively. One intraoperative complication occurred (2.5%), and 7 postoperative complications occurred in 6 patients (15%). During a median follow-up time of 8 months (IQR: 1-15), none of the patients developed AMLrelated symptoms. The median eGFR preservation rate was 95%. There were no differences in operative or perioperative outcomes between patients who underwent SAE before surgery and those who did not.
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THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 CONCLUSIONS: RAPN appears to be a safe primary or secondary (post-SAE) treatment for large AMLs, with favorable perioperative morbidity profile and excellent functional preservation. Longer follow-up is required to fully evaluate therapeutic efficacy.
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MP49-16 MODIFIED LAPAROSCOPIC SIMPLE ENUCLEATION WITH SINGLE LAYER SUTURE TECHNIQUE VERSUS STANDARD LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR TREATING LOCALIZED RENAL CELL CARCINOMA
Qun Lu*, Xiaozhi Zhao, Changwei Ji, Guangxiang Liu, Hongqian Guo, Nanjing, China, People's Republic of INTRODUCTION AND OBJECTIVES: Laparoscopic simple enucleation, which appears to reserve more renal parenchyma without compromising oncologic safety, may be an alternative to standard laparoscopic partial nephrectomy (SLPN). The aim of the present study is to examine the impact of modified laparoscopic simple enucleation (MLSE) with single layer suture technique versus SLPN on our large institutional experience in terms of intraoperative, early postoperative and pathologic outcomes.
METHODS: We evaluated 385 consecutive patients who underwent MLSE or SLPN for renal tumors in our institution from January 2013 to December 2015 in terms of perioperative pathologic and oncologic outcome variables. In MLSE, the pseudocapsule of the tumor is bluntly dissected along a natural tissue plane without a visible rim of normal parenchyma. The single layer suture technique was performed for renal reconstruction.
RESULTS: In total, 280 patients underwent MLSE and 105 underwent SLPN. The PADUA score was ¼ 10 for 62 (22.2%) MLSE patients and 12 (11.4%) SLPN patients (p¼0.017). Highly-complex renal tumors (PADUA score ¼ 10) were mostly enucleated. Mean operative time was 182.1 and 192.8 min, respectively (p¼0.078). Warm ischemic time was significantly lower in the MLSE than SLPN group (23.2 vs 25.4 min; p¼0.004). The estimated blood loss was similar (p¼0.537). Tumor bed suturing was performed in 9.3% and 82.9% of MLSE and SLPN cases (P¼0.000). No hilar clamping was needed for 29 MLSE patients (10.4%) and 4 SLPN patients (3.8%) (p¼0.041). Grade III complications were reported in 5 (1.8%) MLSE patients and 7 (6.6%) SLPN patients (p¼0.034). The incidence of positive surgical margins was comparable between the MLSE and SLPN groups (1.8% and 5.7%, p¼ 0.086). After a median follow-up of 18 months, recurrence did not differ between the 2 groups: 9 (3.2%) MLSE patients and 4 (3.8%) SLPN patients (p¼1.000).
CONCLUSIONS: MLSE may confer shorter warm ischemic time, almost no need for tumor bed suturing and less Grade III complications than SLPN, with similar oncologic outcomes. MLSE may be safe and acceptable for patients undergoing Nephron-sparing surgery.
